CorMedix Inc.
CRMD•NASDAQ•Healthcare•Biotechnology

About CorMedix

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOJoseph Todisco
Founded2006
IPO DateMarch 25, 2010
Employees65
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock
Share ClassClass A Shares

Contact Information

Websitewww.cormedix.com
Phone908 517 9500
Address
300 Connell Drive, Suite 4200 Berkeley Heights, New Jersey 07922 United States

Corporate Identifiers

CIK0001410098
CUSIP21900C308
ISINUS21900C3088
SIC2834

Leadership Team & Key Executives

Joseph Todisco MBA
Chief Executive Officer and Director
Elizabeth Masson-Hurlburt B.A.
Executive Vice President, Chief Operating Officer and Chief Integration Officer
Dr. Matthew T. David M.D.
Executive Vice President and Chief Business Officer
Susan Blum
Executive Vice President and Chief Financial Officer
Kaufman Beth Zelnick Esq.
EVice President, Chief Legal and Compliance Officer and Corporate Secretary
Beth Steinbrenner
SVice President and Chief Human Resource Officer
Donna Ucci
Senior Vice President and Head of Global Quality
Dr. Tushar Mukherjee
Senior Vice President and Head of Technical Operations